Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NI-071 vs Infliximab in Rheumatoid Arthritis
NCT01927263Phase 3Completed
- Sponsor
- Nichi-Iko Pharmaceutical
- Start
- Jul 2013
- Primary completion
- Mar 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of GS07 in rheumatoid arthritis (RA), sponsored by Nichi-Iko Pharmaceutical. Started Jul 2013; status: completed.
02
Drugs
GS07
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01927263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01927263.